98 related articles for article (PubMed ID: 16761309)
1. MEK kinase 1 is a negative regulator of virus-specific CD8(+) T cells.
Labuda T; Christensen JP; Rasmussen S; Bonnesen B; Karin M; Thomsen AR; Odum N
Eur J Immunol; 2006 Aug; 36(8):2076-84. PubMed ID: 16761309
[TBL] [Abstract][Full Text] [Related]
2. Frontline: An in-depth evaluation of the production of IL-2 by antigen-specific CD8 T cells in vivo.
D'Souza WN; Lefrançois L
Eur J Immunol; 2004 Nov; 34(11):2977-85. PubMed ID: 15384078
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cells inhibit the CD8 T cell response during low-dose virus infection.
Cose S; Brammer C; Zammit DJ; Blair DA; Lefrançois L
Int Immunol; 2006 Aug; 18(8):1285-93. PubMed ID: 16769750
[TBL] [Abstract][Full Text] [Related]
4. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production.
Gallagher E; Enzler T; Matsuzawa A; Anzelon-Mills A; Otero D; Holzer R; Janssen E; Gao M; Karin M
Nat Immunol; 2007 Jan; 8(1):57-63. PubMed ID: 17143273
[TBL] [Abstract][Full Text] [Related]
5. Priming of CD8+ T cell responses by pathogens typically depends on CD70-mediated interactions with dendritic cells.
Schildknecht A; Miescher I; Yagita H; van den Broek M
Eur J Immunol; 2007 Mar; 37(3):716-28. PubMed ID: 17295392
[TBL] [Abstract][Full Text] [Related]
6. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
[TBL] [Abstract][Full Text] [Related]
7. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
[TBL] [Abstract][Full Text] [Related]
8. Expression of lymphotoxin beta governs immunity at two distinct levels.
Junt T; Tumanov AV; Harris N; Heikenwalder M; Zeller N; Kuprash DV; Aguzzi A; Ludewig B; Nedospasov SA; Zinkernagel RM
Eur J Immunol; 2006 Aug; 36(8):2061-75. PubMed ID: 16841297
[TBL] [Abstract][Full Text] [Related]
9. IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cells.
Itsumi M; Yoshikai Y; Yamada H
Eur J Immunol; 2009 Jul; 39(7):1784-93. PubMed ID: 19544306
[TBL] [Abstract][Full Text] [Related]
10. Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation.
Thompson LJ; Kolumam GA; Thomas S; Murali-Krishna K
J Immunol; 2006 Aug; 177(3):1746-54. PubMed ID: 16849484
[TBL] [Abstract][Full Text] [Related]
11. Perforin and IFN-gamma do not significantly regulate the virus-specific CD8+ T cell response in the absence of antiviral effector activity.
Christensen JE; Wodarz D; Christensen JP; Thomsen AR
Eur J Immunol; 2004 May; 34(5):1389-94. PubMed ID: 15114672
[TBL] [Abstract][Full Text] [Related]
12. Persistent antigen presentation after acute vesicular stomatitis virus infection.
Turner DL; Cauley LS; Khanna KM; Lefrançois L
J Virol; 2007 Feb; 81(4):2039-46. PubMed ID: 17151119
[TBL] [Abstract][Full Text] [Related]
13. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
[TBL] [Abstract][Full Text] [Related]
14. JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response.
Tao J; Gao Y; Li MO; He W; Chen L; Harvev B; Davis RJ; Flavell RA; Yin Z
Eur J Immunol; 2007 Mar; 37(3):818-29. PubMed ID: 17301952
[TBL] [Abstract][Full Text] [Related]
15. IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells.
Denton AE; Doherty PC; Turner SJ; La Gruta NL
Eur J Immunol; 2007 Feb; 37(2):368-75. PubMed ID: 17219365
[TBL] [Abstract][Full Text] [Related]
16. Progression of a vesicular stomatitis virus infection in primary lymphocytes is restricted at multiple levels during B cell activation.
Schmidt MR; Gravel KA; Woodland RT
J Immunol; 1995 Sep; 155(5):2533-44. PubMed ID: 7650383
[TBL] [Abstract][Full Text] [Related]
17. Oncolytic immunovirotherapy for melanoma using vesicular stomatitis virus.
Diaz RM; Galivo F; Kottke T; Wongthida P; Qiao J; Thompson J; Valdes M; Barber G; Vile RG
Cancer Res; 2007 Mar; 67(6):2840-8. PubMed ID: 17363607
[TBL] [Abstract][Full Text] [Related]
18. Impact of macrophage and dendritic cell subset elimination on antiviral immunity, viral clearance and production of type 1 interferon.
Ciavarra RP; Taylor L; Greene AR; Yousefieh N; Horeth D; van Rooijen N; Steel C; Gregory B; Birkenbach M; Sekellick M
Virology; 2005 Nov; 342(2):177-89. PubMed ID: 16143360
[TBL] [Abstract][Full Text] [Related]
19. Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+ T cells by mouse liver.
Kuniyasu Y; Marfani SM; Inayat IB; Sheikh SZ; Mehal WZ
Hepatology; 2004 Apr; 39(4):1017-27. PubMed ID: 15057906
[TBL] [Abstract][Full Text] [Related]
20. Variable immune response against a developmentally regulated self-antigen.
Steinhoff U; Maloy KJ; Burkhart C; Clark AJ; Rülicke T; Hengartner H; Zinkernagel RM
J Autoimmun; 1999 Feb; 12(1):27-34. PubMed ID: 10028019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
